KI-Beratung Beta

Gutscheinbedingungen

**Gültig bis 18.11.2026 auf englischsprachige Klassiker (klassiker-32728) online auf thalia.at und in der Thalia App. Einzelne Artikel können ausgeschlossen sein. Ausgenommen sind preisgebundene Artikel & eBooks. Pro Einkauf einmal einlösbar. Click & Collect nur bei Onlinevorabzahlung möglich. Keine Barauszahlung. Nicht kombinierbar mit anderen Aktionen und Gutscheinen. Gutschein wird auf max. 500€ Bestellwert angerechnet. Nicht gültig für Geschenkkarten, Versandkosten und Services.

Produktbild: New Oxford Textbook of Psychiatry

New Oxford Textbook of Psychiatry

557,99 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Over its two editions, The New Oxford Textbook of Psychiatry has come to be regarded as one of the most popular and trusted standard psychiatry texts among psychiatrists and trainees.

Beschreibung

Over its two editions, The New Oxford Textbook of Psychiatry has come to be regarded as one of the most popular and trusted standard psychiatry texts among psychiatrists and trainees.

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

09.06.2020

Herausgeber John R. Geddes + weitere
Verlag Oxford Academic

Produktdetails

Einband

Gebundene Ausgabe

Erscheinungsdatum

09.06.2020

Herausgeber
Verlag Oxford Academic
Seitenzahl

1536

Maße (L/B/H)

28,2/23/6 cm

Gewicht

3655 g

Auflage

3rd edition

Sprache

Englisch

ISBN

978-0-19-871300-5

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: New Oxford Textbook of Psychiatry
    • Section 1: The subject matter and approach to psychiatry
    • 1: Kay Redfield Jamison and Adam Ian Kaplin: The patient's perspective
    • 2: Nicole Votruba, Mirja Koschorke, and Graham Thornicroft: Public attitudes and the challenge of stigma
    • 3: Crick Lund, Dörte Bemme, and Judy Bass: Global mental health
    • 4: Pierre Pichot: The history of psychiatry as a medical specialty
    • 5: Ilina Singh, Julian Savulescu, and Matthew L. Baum: A new ethics for 21st century psychiatry
    • 6: Hans-Jürgen Möller: Foundations of phenomenology / descriptive psychopathology
    • 7: Darrel A. Regier, David P. Goldberg, Geoffrey M. Reed and Bedirhan T. Ustun: DSM-5 and ICD-11 classifications
    • 8: Charles A. Sanislow, Sarah E. Morris, Jennifer Pacheco, and Bruce N. Cuthbert: The National Institute of Mental Health Research Domain Criteria: An alternative framework to guide psychopathology research
    • 9: Andrea Cipriani, Stefan Leucht, and John R. Geddes: Application of research evidence in clinical practice
    • 10: Guy M. Goodwin, Joseph Zohar, and David J. Kupfer: A neuroscience based nomenclature for psychotropic drugs
    • Section 2: The scientific basis of psychiatric aetiology and treatment
    • 11: Karl Zilles and Nicola Palomero-Gallagher: Neuroanatomy
    • 12: Mark Woolrich, Mark Jenkinson, and Clare Mackay: Neuroimaging technologies
    • 13: Olaf Sporns: The connectome
    • 14: Trevor Sharp: Neurotransmitters and signalling
    • 15: Juan C. Leza, Javier R. Caso, and Borja García-Bueno: Psychoneuroimmunology
    • 16: Caleb Webber: Functional genomics
    • 17: Anna Christina Nobre: Cognitive neuroscience: Principles and methods
    • 18: Verena Heise, Enik? Zsoldos, and Klaus P. Ebmeier: Ageing and the human brain
    • 19: Helen S. Mayberg, Andrea Cowell, and Patricio Riva Posse: Development of brain stimulation
    • 20: Amy Chan and Rob Horne: Adherence to treatment in psychiatry
    • Section 3: Intellectual disabilities
    • 21: Anthony J. Holland: Core dimensions of intellectual disabilities
    • 22: Sally-Ann Cooper: Epidemiology and course of intellectual disabilities
    • 23: Judith L. Rapoport, Dale Zhou, and Kwangmi Ahn: Aetiology of intellectual disability: General issues and prevention
    • 24: José-Luis Ayuso-Mateos and Cary S. Kogan: Management and treatment of intellectual disability
    • Section 4: Autism spectrum disorders
    • 25: Fred R. Volkmar and Scott L. J. Jackson: Core dimensions of autism spectrum disorders
    • 26: Emily J. H. Jones: Basic mechanisms and treatment targets for autism spectrum disorders
    • 27: Charles R. Newton: Epidemiology of autism
    • 28: Abha R. Gupta, Thomas V. Fernandez, and Ellen J. Hoffman: Genetics of autism spectrum disorders
    • 29: Christine Eckera and Declan Murphy: Imaging of autism spectrum disorders
    • 30: Emily Simonoff: Management and treatment of autism spectrum disorders
    • Section 5: Attention deficit and hyperactivity disorder
    • 31: Eric Taylor: Core dimensions of attention deficit hyperactivity disorder
    • 32: Barbara Franke and Jan K. Buitelaar: Basic mechanisms and treatment planning / targets for attention deficit hyperactivity disorder
    • 33: Guilherme V. Polanczyk: Epidemiology of attention deficit hyperactivity disorder and the implications for its prevention
    • 34: Kate Langley and Anita Thapar: Genetics of attention deficit hyperactivity disorder
    • 35: Philip Shaw and Eszter Szekely: Insights from neuroanatomical imaging into attention deficit hyperactivity disorder throughout the lifespan
    • 36: Alessandro Zuddas and Sara Carucci: Management and treatment of attention deficit hyperactivity disorder
    • Section 6: Motor disorders
    • 37: Davide Martino and Antonella Macerollo: Neurodevelopmental motor disorders
    • Section 7: Delirium, dementia, and other cognitive disorders
    • 38: Noel J. Buckley and George K. Tofaris: Pathways of neurodegeneration underlying dementia
    • 39: Ravi S. Bhat and Kenneth Rockwood: Delirium
    • 40: Ivan Koychev and John Gallacher: Alzheimer's disease
    • 41: Akitoshi Takeda and Bruce Miller: Frontotemporal dementias
    • 42: Akin Nihat, TzeHow Mok, and John Collinge: Prion disease
    • 43: Anto P. Rajkumar and Dag Aarsland: Dementia with Lewy bodies
    • 44: Michele Hu and Fahd Baig: Dementia in Parkinson's disease
    • 45: Russell L. Margolis: Dementia due to Huntington's disease
    • 46: Joanne A. Byars and Ricardo E. Jorge: Vascular cognitive impairment
    • 47: Christian Lepage, Inga K. Koerte, Vivian Schultz, Michael J. Coleman, and Martha E. Shenton: Traumatic brain injury
    • Section 8: Substance use disorders
    • 48: Trevor W. Robbins and Barry J. Everitt: Substance use disorders and the mechanisms of drug addiction
    • 49: Yann Le Strat, Nicolas Ramoz, and Philip Gorwood: Genetics of substance use disorders
    • 50: Wim van den Brink and Falk Kiefer: Alcohol use disorder
    • 51: Michael Farrell, Briony Larance, and Courtney Breen: Opiates: Heroin, methadone, buprenorphine
    • 52: David J. Castle: Cannabis and mental illness
    • 53: Adam R. Winstock and Remy Flechais: Stimulants, ecstasy, and other party drugs
    • 54: Adam Winstock and James Rucker: Psychedelics and dissociative substances
    • 55: Marcus Munafo and Meryem Grabski: Tobacco addiction
    • 56: Julia M. A. Sinclair and Anne Lingford-Hughes: Co-morbidity of substance use and psychiatric disorders
    • Section 9: Schizophrenia and psychotic disorders
    • 57: Nancy C. Andreasen: The core dimensions of schizophrenia
    • 58: Assen Jablensky: Epidemiology and course of schizophrenia
    • 59: Kimberley M. Kendall, James T. R. Walters and Michael C. O Donovan: Genetics of schizophrenia
    • 60: Andreea O. Diaconescu, Sandra Iglesias, and Klaas E. Stephan: Structural and functional neuroimaging of schizophrenia
    • 61: William S. Stone, Stephen V. Faraone and Ming T. Tsuang: Schizoaffective and schizotypal disorders / acute and transient psychotic disorders
    • 62: Andreas Marneros: Delusional disorders
    • 63: Emre Bora, Mahesh Jayaram, and Christos Pantelis: Prevention and early intervention in psychotic disorders
    • 64: Herbert Y. Meltzer and William V. Bobo: Antipsychotic and anticholinergic drugs
    • 65: Joseph P. McEvoy, Kammarauche Asuzu, Daniel W. Bradford, Oliver Freudenreich, and Katherine Moyer: The treatment and management of patients with schizophrenia
    • Section 10: Mood disorders
    • 66: S. Nassir Ghaemi and Sivan Mauer: Diagnosis, classification and differential diagnosis of mood disorders
    • 67: Lars Vedel Kessing: Epidemiology of mood disorders
    • 68: Gin S. Malhi: Primary prevention of mood disorders: Building a target for prevention strategies
    • Section 11: Bipolar disorder
    • 69: Grant C. Churchill, Nisha Singh, and Michael J. Berridge: Basic mechanisms of and treatment targets for bipolar disorder
    • 70: Francis J. MacMahon and Sevilla Detera-Wadlieigh: Genetics of bipolar disorder
    • 71: Mary L. Phillips and Wayne C. Drevets: Neuroimaging of bipolar disorder
    • 72: Eduard Vieta, Isabella Pacchiarotti, and David J. Miklowitz: Management and treatment of bipolar disorder
    • 73: Ian Jones and Arianna Di Florio: Perinatal psychiatry
    • Section 12: Depressive disorders
    • 74: Marcela Pereira, Roberto Andreatini, and Per Svenningsson: Basic mechanisms of and treatment targets for depressive disorders
    • 75: Alison K. Merikangas and Kathleen R. Merikangas: Genetic epidemiology of depression in the molecular era
    • 76: Guy M. Goodwin and Michael Browning: Imaging of depressive disorders
    • 77: Philip J. Cowen: Management and treatment of depressive disorders
    • Section 13: Trauma and stress or related and adjustment disorders
    • 78: Dean G. Kilpatrick, Matthew J. Friedman, and Amanda K. Gilmore: Classification and descriptive psychopathology of posttraumatic stress disorder and other stressor-related disorders
    • 79: Bruce S. McEwen: Basic mechanisms of and treatment targets for stress-related disorders
    • 80: Michael G. Gottschalk and Katharina Domschke: Genetics of stress-related disorders
    • 81: Navneet Kaur, Cecilia Hinojosa, Julia Russell, Michael B. Van Elzakker, and Lisa M. Shin: Imaging of stress-related disorders
    • 82: Maria Bragesjö, Emily A. Holmes, Filip Arnberg, and Erik M. Andersson: Primary prevention and epidemiology of trauma and stress related disorders
    • 83: Leigh van den Heuvel and Soraya Seedat: Management and treatment of stress-related disorders
    • 84: Beverley Raphael, Sally Wooding, and Julie Dunsmore: Bereavement
    • 85: Deborah Davis and Elizabeth F. Loftus: Recovered memories and false memories
    • Section 14: Anxiety disorders
    • 86: Nastassja Koen and Dan J. Stein: Core dimensions of anxiety disorders
    • 87: Martien Kas and Berend Olivier: Basic mechanisms, genetics, targets and animal models for anxiety disorders
    • 88: Hans-Ulrich Wittchen and Katja Beesdo-Baum: Epidemiology and course of anxiety disorders
    • 89: Michael G. Gottschalk and Katharina Domschke: Genetics of anxiety disorders
    • 90: Gregor Leicht and Christoph Mulert: Neuroimaging of anxiety disorders
    • 91: Aliza Werner-Seidler, Jennifer L. Hudson, and Helen Christensen: The primary prevention of anxiety disorders
    • 92: David S. Baldwin and Nathan T. M. Huneke: Treatment of anxiety disorders
    • Section 15: Obsessive-compulsive and related disorders
    • 93: Sophie C. Snyder, Eric A. Storch, and Wayne K. Goodman: Core dimensions of obsessive-compulsive disorder
    • 94: Eric Burguière and Luc Mallet: Basic mechanisms of and treatment / planning targets for obsessive-complusive disorder
    • 95: Lior Carmi, Naomi A. Fineberg, Oded Ben-Arush, and Joseph Zohar: Obsessive-compulsive disorder
    • 96: Gerald Nestadt and Jack Samuels: Genetics of obsessive-compulsive disorder
    • 97: Rebbia Shahab and Emily R. Stern: Imaging of obsessive-compulsive disorder
    • 98: Naomi A. Fineberg, Lynne M. Drummond, Jemma Reid, Eduardo Cinosi, Lior Carmi, and Davis N. Mpavaenda: Management and treatment of obsessive-compulsive disorder
    • 99: Lorena Fernández de la Cruz and David Mataix-Cols: Hoarding disorder
    • 100: Megan M. Kelly and Katharine A. Phillips: Body dysmorphic disorder
    • Section 16: Feeding and eating disorders
    • 101: Chris Fairburn and Rebecca Murphy: The eating disorders
    • 102: Johannes Hebebrand, Jochen Antel, and Beate Herpertz-Dahlmann: Basic mechanisms and potential for treatment of weight and eating disorders
    • 103: Katherine A Halmi: Epidemiology and primary prevention of feeding and eating disorders
    • 104: Christopher Hüble, Cynthia Bulik, and Gerome Breen: Genetics of feeding and eating disorders
    • 105: Natalie Kurniadi, Christina E. Wierenga, Laura A. Berner, and Walter H. Kaye: Imaging of feeding and eating disorders
    • 106: Susan L. McElroy, Anna I. Guerdjikova, Nicole Mori, Paul L. Houser, and Paul E. Keck, Jr.: Management and treatment of feeding and eating disorders
    • 107: Jamie Hartmann-Boyce, Nerys M. Astbury, and Susan A. Jebb: Aetiology and management of obesity
    • 108: Alexander von Gontard: Elimination disorders in children and adolescents
    • Section 17: Sleep wake disorders
    • 109: David Pritchett, Angus S. Fisk, Russell G. Foster, and Stuart N. Peirson: Basic mechanisms of and treatment targets for sleep-wake disorders
    • 110: Kirstie Anderson: Diagnosis of sleep and circadian rhythm disorder
    • 111: Lena Katharina Keller, Eva C. Winnebeck, and Till Roenneberg: Epidemiology of sleep-wake and primary prevention of its disorders
    • 112: Diego R. Mazzotti, Allan I. Pack, and Philip R. Gehrman: Genetics of sleep-wake disorders
    • 113: Umberto Moretto, Dylan Smith, Liliana Dell Osso, and Thien Thanh Dang-Vu: Multi-modal imaging of sleep-wake disorders
    • 114: Simon D. Kyle, Alasdair L. Henry, and Colin A. Espie: Management of insomnia and circadian rhythm sleep-wake disorders
    • Section 18: Sexual function and sexual dysfunction
    • 115: Cynthia A. Graham and John Bancroft: The sexual dysfunctions and paraphilias
    • 116: Els Elaut and Gunter Heylens: Gender dysphoria
    • Section 19: Personality disorders
    • 117: Andrew E. Skodol and Leslie C. Morey: Core dimensions of personality pathology
    • 118: Kate E. A. Saunders and Steve Pearce: Basic mechanisms of and treatment planning / targets for personality disorders
    • 119: Renato D. Alarcón and Brian A. Palmer: Personality disorders: Epidemiology and clinical course
    • 120: C. Robert Cloninger: Genetics of personality disorders
    • 121: Christian Paret and Christian Schmahl: Imaging of personality disorders
    • 122: Giles Newton-Howes and Roger Mulder: Treatment and management of personality disorder
    • Section 20: Impulse control and conduct disorders
    • 123: Donald W. Black: Impulse control and its disorders: including pathological gambling
    • 124: Stephen Scott and Melanie Palmer: Conduct disorders and antisocial personality disorder in childhood and adolescence
    • Section 21: Suicide
    • 125: Merete Nordentoft, Trine Madsen, and Annette Erlangsen: Epidemiology and causes of suicide
    • 126: Nav Kapur, Sarah Steeg, and Adam Moreton: Self-harm: Epidemiology and risk factors
    • 127: J. John Mann and Dianne Currier: Biological aspects of suicidal behaviour
    • 128: Keith Hawton, Kate E. A. Saunders, and Alexandra Pitman: Prevention of suicide and treatment following self-harm
    • Section 22: Somatic symptoms and related disorders
    • 129: Michael Sharpe and Jane Walker: Deconstructing dualism: The interface between physical and psychological illness
    • 130: Chantal Berna and Irene Tracey: Neural mechanisms in chronic pain relevant for psychiatric interventions
    • 131: Jonathan Price: Treatment of fibromyalgia (chronic widespread pain) and chronic fatigue syndrome
    • 132: Thomas Merten and Harald Merckelbach: Factitious disorder and malingering
    • 133: Jon Stone and Michael Sharpe: Functional neurological symptom disorder (Conversion disorder)
    • Section 23: Service provision
    • 134: Martin Knapp: Public policy and service needs in mental health
    • 135: Tom Burns and Tony Kendrick: Planning and providing mental health services for a community
    • 136: Judit Simon: Health economic analysis of service provision
    • 137: William H. Sledge and Julianne Dorset: The organization of psychiatric services for general hospital departments: Proactive and preventive interventions in psychiatry
    • 138: Mina Fazel, Susan Rees, and Derrick Silove: Refugees and populations exposed to mass conflict
    • Section 24: Forensic psychiatry
    • 139: Seena Fazel and Mark Toynbee: Associations between psychiatric disorder and offending
    • 140: Sue Bailey and Prathiba Chitsabesan: Developmental approach to understanding the needs of young people in contact with the criminal justice system
    • 141: Stephen J. Hucker: Child molesters and other sexual offenders
    • 142: Rosemary Purcell and Paul E. Mullen: Stalking and querulous behaviour
    • 143: Louise M. Howard and Deirdre MacManus: Domestic violence and abuse and mental health
    • 144: Alec Buchanan: Assessing and managing the risk of violence towards others
    • 145: John O Grady: The expert witness in the criminal and civil courts
    • 146: Matthew Large and Olav Nielssen: Homicide